Skip to content

A Randomized Controlled Trial Evaluating the Role of Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary Surgery

Negative Pressure Wound Therapy (NPWT) for Incisional Surgical Site Infections in Patients Undergoing Hepatopancreatobiliary Surgery: A Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05481398
Acronym
NPWT
Enrollment
46
Registered
2022-08-01
Start date
2021-03-06
Completion date
2022-07-01
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatobiliary Disease, Hepatobiliary Disorders, Surgical Site Infection

Keywords

Hepatopancreatobiliary surgery, Surgical site infection, Negative pressure wound therapy

Brief summary

To compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.

Interventions

OTHERNegative Pressure Wound Therapy

The wound is dressed using negative pressure wound therapy comprising of a single layer of sterile gauze followed by placement of a 18 Fr nelaton catheter and the wound further covered with 4 more layers of sterile gauze over the nelaton catheter. The wound is then covered with opsite dressing making it airtight. The nelaton catheter is attached to the wall suction port once the patient is shifted to the bed with pressure set at - 25 mm Hg.

Sponsors

Murk Niaz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Two individuals were assigned the role of outcome assessors to examine the wound after removal of the dressing and score the wound for infection using the ASEPSIS score.

Intervention model description

Randomization Patients will be randomly allocated into intervention group A (NPWT) or control group (B) by simple randomization.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients undergoing elective open HPB surgery (benign or malignant disease) of age \> 18 years consenting to the study protocol.

Exclusion criteria

The patient in which primary wound closure is not achieved. The patient planned for a second look surgery. The patient with the history of long-term antibiotic use (more than a month). Past history of open abdominal surgery (less than 1 month).

Design outcomes

Primary

MeasureTime frameDescription
Rate of incisional surgical site infections (iSSIs)within 7 days of hepatopancreatobiliary (HPB) surgeryTo compare the rates of incisional surgical site infections (iSSIs) within 7 days of hepatopancreatobiliary (HPB) surgery using negative pressure wound therapy (NWPT) versus using standard sterile gauze dressing.

Secondary

MeasureTime frameDescription
Antibiotic therapyDay 1 to day 30Need for antibiotic therapy for iSSI beyond perioperative/postoperative surgical prophylaxis.
Length of hospital stay.Day 1 to day 30Length of hospital stay.
Wound infectionsday 7 till 30 days following HPB surgeryWound infections after day 7 till 30 days following HPB surgery.
Surgical site complicationwithin 30 days of HPB surgerySurgical site complication (hematoma/seroma/wound dehiscence) within 30 days of HPB surgery.
Rate of fascial dehiscencewithin 30 days of HPB surgeryRate of fascial dehiscence within 30 days of HPB surgery.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026